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Abstract
Background: Data about the burden of extended-spectrum beta-lactamase (ESBL)-producing microorganisms in
Africa are limited. Our study aimed to estimate the prevalence of human faecal ESBL carriage in the community of
an informal urban settlement in Dar es Salaam (Tanzania, East Africa) by using environmental contamination of
household latrines with ESBL as a surrogate marker.
Methods: Within the context of a large survey in February 2014 assessing 636 randomly selected household
latrines for faecal contamination by the detection of growth of E. coli and total faecal coliform bacteria, a randomly
selected subset of the samples were screened for ESBL.
Results: Seventy latrines were screened for ESBL. An average of 11.4 persons (SD ±6.5) were sharing one latrine.
Only three (4.3%) latrines had hand-washing facilities and 50 showed faeces on the floor. ESBL-producing
Enterobacteriaceae were confirmed in 17 (24.3%) of the 70 latrine samples: 16 E. coli and 1 Klebsiella pneumoniae.
Five ESBL E. coli strains were detected on door handles. The most prevalent ESBL type was CTX-M-1 group (76.5%).
Pulsed-field gel electrophoresis typing of a subset of ESBL-producing E. coli isolates revealed both diverse singular
types and a cluster of 3 identical isolates. There was no significant difference of the latrine and household
characteristics between the group with ESBL (n = 17) and the group with non-ESBL E. coli (n = 53) (p > 0.05).
Conclusions: Almost a quarter of private and shared latrines in an informal urban settlement in Tanzania are
contaminated with ESBL-producing microorganisms, suggesting a high prevalence of human ESBL faecal carriage in
the community. Shared latrines may serve as a reservoir for transmission in urban community settings in Tanzania.
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Background
Extended-spectrum beta-lactamase (ESBL)-producing gram-
negative bacteria have become an emerging global health
threat and have been associated with high mortality [1, 2].
Whereas ESBL infections were initially associated with
nosocomial outbreaks, there is now increasing recogni-
tion of high rates of faecal carriage and the importance
of community-acquired infections due to ESBL-producing
Escherichia coli in industrialized countries [3, 4].
Data about the prevalence of ESBL-producing micro-
organisms in Africa are limited. A wide variation from
0.6% up to 77.8% has been reported in hospital-based
surveys of clinical isolates [5–11]. There is little pub-
lished data on the magnitude of the community carriage
of ESBL in African countries like Tanzania.
Our study aimed to estimate the prevalence of human
faecal ESBL carriage in the community in an urban
setting in Tanzania, East Africa, by using environmental
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contamination of household latrines with ESBL as a sur-
rogate marker.
Methods
The study was performed in February 2014 in an urban
study site in Keko Machungwa, part of the largest un-
planned and under-serviced settlement in Temeke district,
Dar es Salaam, Tanzania.
Within the context of a large survey assessing the im-
provement of sanitation facilities [12], 636 randomly
selected household latrines were screened for the pres-
ence and concentration of faecal contamination (E. coli
and total faecal coliform bacteria) [13]. Surface swipe
swabs from high frequency contact points (10 cm2) like
door handle and footrest were taken and analysed using
direct membrane filtration technique (Merck Millipore,
Billerica, MA, USA) with commercial medium m-
ColiBlue® (HACH, Loveland, CO, USA) [14]. In this
survey, 492 latrines showed growth of E. coli or coliform
bacteria either at the footrest, the door handle or both
(unpublished data, Fig. 1).
From latrines with E. coli growth, samples were selected
using a calculator based random number generator and
further screened for ESBL-producing Enterobacteriaceae
using the chromogenic selective culture medium chromID®
ESBL (bioMérieux, Marcy-l’Étoile, France) according to
the manufacturer’s instructions. ESBL or carbapenemase
production was confirmed with standard microbiological
techniques following EUCAST guideline [15]. ESBL mo-
lecular types (specifically CTX-M-1 and CTX-M-9 groups)
were determined by isothermal amplification (eazyplex®
SuperBug CRE Assay [Amplex Biosystems, Gießen,
Germany] for use on Genie® II platform [Optigene,
Horsham, UK]). Antimicrobial susceptibility testing and in-
terpretation was done using Vitek® 2 automated system
(bioMérieux) or Etest® (bioMérieux) according to EUCAST
clinical breakpoints (version 5.0, 2015; http://www.eucas-
t.org/clinical_breakpoints). Molecular typing was per-
formed by pulsed-field gel electrophoresis (PFGE) as
described previously [16].
Fig. 1 ESBL screening algorithm. ESBL, extended-spectrum
beta-lactamase-producing microorganisms
Table 1 Baseline characteristics of latrines screened for ESBL (n = 70)
Characteristics
Screened latrines (n, %) 70 100%
Households sharing one latrine (n, %)
1 houshold (private latrine) 24 34.3%
2 households 26 37.1%
3 households 13 18.6%
4–10 households 4 5.7%
10–23 households 3 4.3%
Persons sharing one latrine (mean, ±SD) 11.4 6.5
Household leader male (n, %) 23 32.9%
Household leader’s educational level (n, %)
none 5 7.1%
primary school 43 61.4%
secondary school 22 31.4%
Household leader’s monthly income in
US$ (mean, ±SD)
102.7 78.9
Latrines used by children <5 years (n, %) 58 82.9%
Latrines with stored bucket for anal
cleaning (n, %)
26 37.1%
Handwashing facilities <1 m (n, %) 3 4.3%
Soap available in latrine (n, %) 6 8.6%
Age of latrines in years (mean, ±SD) 4.6 3.4
Latrine floor material (n, %)
brick 60 85.7%
cement 10 14.3%
Cracked or broken slab (n, %) 54 77.1%
Condition of latrine (n, %)
clean 20 28.6%
Dirty - faeces on the floor 50 71.4%
Lid available (n, %) 3 4.3%
Latrine separation (n,%)
no door 6 8.6%
curtain 5 7.1%
wood door 59 84.3%
Flies in latrine (n, %) 40 57.1%
Animals in the compound (n, %) 14 20.0%
SD standard deviation
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Data about household and latrine characteristics were
collected by visual inspection and questionnaire.
Univariable analysis was performed by the chi-square
test or Fisher’s exact test, where appropriate, for categor-
ical variables and two-tailed Student’s t test for continuous
variables. Two-tailed p-values of <0.05 were considered
statistically significant.
The study was approved by the national ethics
committee of the National Institute for Medical
Research Tanzania (NIMR/HQ/R.8a/Vol.IX/1632).
Results
From the 492 latrines with growth of E. coli, 70 latrines
were randomly selected for ESBL screening. All 70
latrines had either a cement, tile or brick floor and met
the WHO/UNICEF Joint Monitoring Program for Water
Supply and Sanitation definitions for improved latrines
[12]. Only 3 (4.3%) latrines had hand-washing facilities
and 50 showed faeces on the floor. An average of 11.4
persons (SD ±6.5) were sharing one latrine.
Twenty-four (34.3%) latrines were private (i.e. each of
these latrines were used by only one household), the
remaining latrines were shared by ≥2 households. The
latrines were not accessible for the public but restricted
to individuals living in the respective household
(Table 1).
Forty samples showed ESBL suspected colonies on
chromID® ESBL culture medium. ESBL-producing En-
terobacteriaceae were finally confirmed in 17 (24.3%) of
the 70 latrine samples: 16 E. coli and 1 Klebsiella pneu-
Table 2 Microbiological results of the screened latrines (n = 70)
ESBL-producing bacteria total (n, %) 17 24.3%
ESBL E. coli 16
ESBL K. pneumoniae 1
Screening sites positive (n, %) 17
Footrests 12 70.6%
Door handles ± footrests 5 29.4%
Antibiotics resistant/intermediatea (n, %)
Ampicillin 17 100%
Amoxicillin/Clavulanic acid 16 94.1%
Piperacillin/Tazobactam 4 23.5%
Cefoxitin 11 64.7%
Ceftazidime 16 94.1%
Ceftriaxone 17 100%
Cefepime 16 94.1%
Ertapenem 0 0%
Meropenem 0 0%
Ciprofloxacin 16 94.1%
Tobramycin 15 88.2%
Amikacin 6 35.3%
Trimethoprim/Sulfamethoxazole 14 82.4%
Nitrofurantoin 1 5.9%
Fosfomycin 0 0%
Colistin 0 0%
ESBL types (n, %) 17
CTX-M-1 group 13 76.5%
CTX-M-9 group 1 5.9%
Other than CTX-M-1/9 group 3 17.6%
ESBL extended-spectrum beta-lactamase-producing microorganisms
aInterpretation according to EUCAST breakpoints version 5.0 (2015)
Table 3 Microbiological and household characteristics of the 17 detected ESBL microorganisms
No Sample
ID
ESBL
organism
ESBL
type
Amoxicillin/
Clavulanic
acid
Piperacillin/
Tazobactam
Ceftriaxone Meropenem Amikacin TMP/SMX Nitrofurantoin Ciprofloxacin Fosfomycin Colistin
1 91BH E. coli CTX-M-1 R S R S S S S R S S
2 124CM E. coli CTX-M-1 R R R S S R S R S S
3 107AH E. coli CTX-M-1 R R R S S R S R S S
4 115AH E. coli CTX-M-1 R R R S S R S R S S
5 106CH E. coli other R R R S S R S R S S
6 104DS E. coli other R S R S S R S R S S
7 102DS E. coli CTX-M-1 R S R S R R S R S S
8 90S E. coli other R S R S S R S R S S
9 86BS E. coli CTX-M-1 R S R S S R S R S S
10 84BS E. coli CTX-M-1 R S R S R R S R S S
11 83BS E. coli CTX-M-1 R S R S R R S R S S
12 97DS E. coli CTX-M-1 R S R S R R S R S S
13 93AS E. coli CTX-M-1 R S R S R R S R S S
14 70DS E. coli CTX-M-1 R S R S S S S R S S
15 67BS E. coli CTX-M-9 R S R S S R S R S S
16 94AS E. coli CTX-M-1 R S R S R R S R S S
17 64BA K. pneumoniae CTX-M-1 S S R S S S R S S S
Susceptibility testing according to EUCAST: R resistant or intermediate, S susceptible, TMP/SMX Trimethoprim/Sulfamethoxazole
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moniae (Table 2). Five ESBL E. coli strains were detected
on door handles. Antimicrobial resistance to ciprofloxa-
cin and trimethoprim/sulfamethoxazole was detected in
94.1% and 82.4% of the ESBL isolates, respectively. No
carbapenem resistance or indication for carbapenemase
production was detected. The most prevalent ESBL type
was CTX-M-1 group (76.5%) (Table 2). Microbiological
and household/latrine characteristics of the 17 detected
ESBL microorganisms are summarized in Table 3. PFGE
typing of a subset of ESBL-producing E. coli isolates
revealed both diverse singular types and a cluster of 3
identical isolates (Fig. 2). Ten isolates were nontypable
by PFGE as observed in other studies [17].
There was no significant difference of the latrine and
household characteristics between the group with ESBL (n =
17) and the group with non-ESBL E. coli (n = 53) (p > 0.05).
Discussion
In this study, we found that a quarter of the E. coli from
contaminated latrines in an urban informal settlement in
Dar es Salaam express ESBL, suggesting a high prevalence
of human ESBL faecal carriage in the community, and that
shared latrines may serve as a reservoir for transmission
in urban areas of Tanzania.
In a recent meta-analysis, the median proportion of
ESBL-producing Enterobacteriaceae in patients of
Tanzanian healthcare facilities was 39% (range 14.2–
75.9%) [11]. Only little is known about the ESBL
burden in a community setting in Tanzania. Tellevik
et al. reported an ESBL faecal carriage rate in
healthy community children in Dar es Salaam of
11.6% [18]. An elderly survey from 2004 found ESBL
in 16% of Enterobacteriaceae causing community-
Table 3 Microbiological and household characteristics of the 17 detected ESBL microorganisms (Continued)
No Screening
site
Age of
latrine
in years
Persons
sharing
1 latrine
Children
<5y using
1 latrine
Latrine
floor
material
Condition
of the
slab
Condition
of the
latrine
Lid
available
Latrines with
stored bucket
for anal cleaning
Handwashing
facilities
Soap
available
in latrine
Latrine
separation
Flies
in
latrine
Animals
in the
compound
1 handle 6 14 3 brick broken clean no no no no door yes yes
2 handle 2 6 1 brick broken dirty no yes no no door no no
3 handle 3 2 0 cement broken dirty no yes no yes door yes yes
4 handle 1 5 1 brick broken dirty no yes no no door no no
5 handle 6 6 1 brick broken dirty no no no no curtain no yes
6 floor 0.5 15 1 brick no cracks dirty no no no no door yes no
7 floor 4 15 1 brick broken dirty no no no no door yes no
8 floor 4 15 1 brick broken dirty no no no no door no no
9 floor 0.5 5 1 cement broken dirty yes yes yes yes door no no
10 floor 0.5 23 1 brick broken clean no no no no door yes no
11 floor 0.5 12 2 brick no cracks clean no no no no door yes no
12 floor 2 9 1 cement broken dirty no yes no no door no yes
13 floor 0.5 10 1 brick broken dirty no yes no no door no yes
14 floor 1 15 4 brick broken dirty no no no no door yes no
15 floor 2 4 1 brick broken clean no no no no no yes no
16 floor 9 7 0 cement broken dirty yes no no no curtain yes no
17 floor 6 10 1 brick no cracks clean no no no no door yes yes
Fig. 2 PFGE of seven ESBL-producing E. coli isolates. PFGE, pulsed-field gel electrophoresis; ESBL, extended-spectrum beta-lactamase-producing
microorganisms. PFGE shows a cluster of 3 isolates (107AH, 115AH, 124CM) with identical PFGE band pattern. Other isolates show different
PFGE pattern
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acquired urinary tract infections [19]. Studies from
other African countries like Senegal, Niger and
Madagascar have reported ESBL carriage rates in the
community ranging as high as 10% to 31% [3]. In
cases where they have been identified, CTX-M en-
zymes were predominantly of CTX-M-1 group as in
our isolates.
Community-onset infections with ESBL-producing
pathogens are now increasingly reported. Empirical
and targeted antibiotic treatment of such infections is
challenging particularly in resource-limited countries.
ESBL producing gram-negative bacteria are by defin-
ition resistant to extended-spectrum cephalosporins
and frequently carry additional resistance genes
conferring reduced susceptibility to many other antibi-
otics like e.g. fluoroquinolones. In many cases the
carbapenems remain the only choice for treatment of
infections caused by these resistant bacteria. However,
the access to antimicrobial agents active against ESBL
is limited in many regions of East Africa, thus com-
mon infections with multidrug-resistant pathogens
cannot be treated adequately.
Intestinal colonization with ESBL-producing micro-
organisms may last several weeks, months or even
years and is a potential source for human-to-human
transmission. Precarious hygienic conditions of la-
trines, which are commonly shared amongst different
households and household members, and the presence
of ESBL-producing microorganisms on door handles
may enable further spread. The cluster of 3 identical
E. coli strains from 3 different latrines detected by
PFGE typing in our study points to the potential of
ESBL transmission in the community.
Our study has limitations: 1) Due to ethical and
logistical reasons rectal swabs were not feasible. How-
ever, environmental samples of the latrines may give a
valuable estimate of the frequency and distribution of
ESBL-producing microorganisms. In addition, there is
a lower risk of selection bias in the community and
the results provide information about potential trans-
mission pathways of multidrug-resistant pathogens in
the community, similar to a recent study from airport
toilet door handles [20]. 2) Our study was restricted to
one informal urban settlement in Dar es Salaam and
might differ from other urban and rural settings in
Tanzania and East Africa. 3) Due to financial con-
straints only 70 latrines could be screened for ESBL.
Conclusions
Our study provides evidence of a high prevalence of hu-
man ESBL faecal carriage in the community of a
resource-limited country such as Tanzania. Further lar-
ger surveillance studies are needed in Africa to better
describe the epidemiology of ESBL, to raise awareness of
the need of strategies to prevent further dissemination,
and to improve the access and responsible use of appro-
priate antimicrobial agents in the empirical treatment of
infections caused by otherwise deadly multidrug-
resistant microorganisms.
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